You are here

  • Home
  • Archive
  • Volume 14, Issue 11
  • Clinical impact of customised positive airway pressure (PAP) therapy interfaces versus usual care in the treatment of patients with sleep-disordered breathing (3DPiPPIn): a randomised controlled trial protocol

Citation Tools

Article menu

Download PDFPDF

Respiratory medicine
Protocol
Clinical impact of customised positive airway pressure (PAP) therapy interfaces versus usual care in the treatment of patients with sleep-disordered breathing (3DPiPPIn): a randomised controlled trial protocol

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Mansell SK, Mandal S, Ridout D, et al
Clinical impact of customised positive airway pressure (PAP) therapy interfaces versus usual care in the treatment of patients with sleep-disordered breathing (3DPiPPIn): a randomised controlled trial protocol
BMJ Open 2024;14:e087234. doi: 10.1136/bmjopen-2024-087234